Precision Medicine

Neurodegenerative Disease Insights Can Advance Precision Medicine

by Erin McNemar, MPA

Rutgers researchers discovered some of the first molecular insights into how toxic proteins are regulated in neurodegenerative disease, potentially advancing precision medicine efforts. The most...

How Proteins in Acute Myeloid Leukemia Support Precision Medicine

by Erin McNemar, MPA

Sanford Burnham Prebys Medical Discovery Institute scientists discovered that the protein RNF5 plays an unusual role in acute myeloid leukemia (AML). By targeting the specific protein, researchers...

Why Genetic Testing Is Key to Advancing Precision Medicine

by Erin McNemar, MPA

Due to genetics, not every patient responds the same to medications. With genetic testing, providers can better determine the best treatment options for individuals, advancing precision...

Precision Medicine Test Predicts Patient Response to Treatment

by Erin McNemar, MPA

A new study indicated that a precision medicine test using blood proteins can identify patients with idiopathic multicentric Castleman disease (iMCD) and are most likely to respond to treatment. The...

Using Predictive, Data Analytics to Expand Knowledge of Alzheimer’s

by Erin McNemar, MPA

Using predictive and data analytics, Brigham and Women’s Hospital researchers developed a resource to better understand the cognitive decline in individuals due to Alzheimer’s disease...

Improving Cancer Treatment, Patient Outcomes with Genomic Testing

by Erin McNemar, MPA

New York University (NYU) is using a new kind of genomic testing to improve cancer treatment and patient outcomes. Cancer has proven to be difficult to manage for patients and healthcare providers....

Determining Family Impact of Genome Sequencing on Newborns

by Erin McNemar, MPA

Genome sequencing can reveal an individual’s risk for specific health conditions throughout their life. While some advocate for testing on all newborns to address disease risks early in life,...

Addressing Cardiovascular Genetic Testing in Children

by Erin McNemar, MPA

According to a new statement from the American Heart Association, cardiovascular genetic testing in children presents challenges that require pre-and post-test counseling with a personalized approach...

HMS, Clalit Collaboration Seeks to Improve Precision Medicine

by Erin McNemar, MPA

Harvard Medical School (HMS) and Clalit Research Institute are launching a collaborative effort to advance precision medicine. The opportunity for collaborations was enabled by a donation from the...

How Broad Data Collection Can Eliminate Health Disparities

by Erin McNemar, MPA

With the use of broad data collection, medical professionals can provide better care for their patients and eliminate health disparities. However, as health analytics advances to improve outcomes for...

Developing Precision Medicine for Chronic Kidney Disease

by Erin McNemar, MPA

In a genome-wide association study, Perelman School of Medicine at the University of Pennsylvania researchers identified 182 genes potentially linked to kidney function and 88 genes for hypertension....

Detecting COVID-19 with Artificial Intelligence, Imaging Technology

by Erin McNemar, MPA

Using artificial intelligence technology, Terasaki Institute for Biomedical Innovation (TIBI) researchers developed and validated an image-based detection model for COVID-19. The model analyzes lung...

Data Analytics Boosts Chronic Pain Management, Personalized Medicine

by Erin McNemar, MPA

University of Pittsburg researchers used a data analytics algorithm to algorithmically cluster individuals with chronic pain by pain distribution, paving the way for better more personalized medicine....

Biomarkers to Improve Precision Medicine for Skin Cancer

by Erin McNemar, MPA

Moffitt Cancer Center researchers discovered a link between cutaneous human papillomavirus and squamous cell carcinomas that could contribute to the development of keratinocyte carcinomas, also known...

Biomarkers to Assist Lung Disease Prognosis, Precision Medicine

by Erin McNemar, MPA

Michigan Medicine researchers have found a protein that could predict the severity of a chronic lung disease that is often fatal in patients with scleroderma. These findings could indicate how...

DNA Tags, Blood Tests Advance Cancer Care, Precision Medicine 

by Erin McNemar, MPA

Georgetown Lombardi Comprehensive Cancer Center researchers are studying DNA tags in blood-based tests to better assess and treat cancer and other diseases using precision medicine. During cell death,...

Genomic Sequencing Creates Precision Medicine for Cancer Patients

by Erin McNemar, MPA

Researchers at St. Jude Children’s Research Hospital have discovered that comprehensive genomic sequencing of all pediatric cancer patients is achievable and essential in the development of...

Addressing Health Disparities by Improving Genomic Research

by Erin McNemar, MPA

According to the American Heart Association, genomic studies have made significant advancements in chronic heart disease prevention. However, these improvements have not been seen equality across all...

Using Precision Medicine to Treat Severe Asthma

by Erin McNemar, MPA

By method of a randomized, placebo-controlled clinical trial, Boston Children’s Hospital will use precision medicine to treat a form of severe asthma to which Black and Latinx children and adults...

Clinical Data, Precision Medicine to Target Improved Cancer Care

by Erin McNemar, MPA

With the goal of using real-world clinical data and precision medicine to deliver better care for cancer patients, MedStar Health and COTA announced a new research partnership. Through the...